Financial analysis of gsk

Slaoui was also Chairman of GSK's vaccine division from until his retirement from the company in June Beginning inhis work unveiled the dynamic nature of HIV replication in vivo and significantly contributed to our understanding of the disease.

Beck has nearly 30 years of pharmaceutical and biotech experience across several therapeutic areas including infectious diseases, metabolic diseases, respiratory, dermatology, and rare diseases. At the same time, the regulatory environment in China has improved significantly. Breakthroughs in science and technology, and advances in digital and data capabilities, are poised to disrupt the discovery, development and delivery of medicines.

He has led investments in a range of life science companies, including biopharmaceuticals, medical devices, diagnostics, and research informatics. Earlier in her career, Dr. Beginning inhis work unveiled the dynamic nature of HIV replication in vivo and significantly contributed to our understanding of the disease.

Ho to champion combination antiretroviral therapy, which resulted in dramatically improved control of HIV in patients. Prior to Gilead, Dr. This knowledge led Dr. Hong started Ardea Biosciences later acquired by AstraZeneca.

Chen holds six issued U. Xu had an illustrious career at Gilead Sciences where she was a senior director, a co-inventor of several successful antiviral therapies, and led the discovery efforts in many therapeutic areas against HIV, HCV, HBV, and cancers resulting in numerous clinical candidates.

A nephrologist and former academic investigator, Dr. Slaoui's career at GSK spanned 29 years, where he sat on its board of directors from May through March Hong is a public health advocate who has helped establish multiple public-private partnerships with the U.

He is also Co-founder of Ctrip.

GlaxoSmithKline PLC (GSK)

Before that, from toMr. Jim Klein Jim Klein is interim Chief Financial Officer with responsibility for finance, treasury, and general administration. She has leadership experience in business development, portfolio management, corporate strategy, alliance management, project management, and clinical development.

Prior to Biogen, Dr. Xu holds a B. Earlier in her career, Dr. Yan was Vice President and Head Unit Physician of GSK Oncology, where he oversaw global development of oncology assets focusing on immunotherapy, cancer epigenetics, and cell therapy. Klein has over 30 years of senior financial leadership experience in the pharmaceutical, biotech, and medical device industries.

He has published over 80 manuscripts and book chapters. Sincehe has co-founded eight companies in the life science arena and co-founded Hatteras Venture Partners in. View GlaxoSmithKline plc GSK investment & stock information.

Get the latest GlaxoSmithKline plc GSK detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Latest Breaking news and Headlines on NeuroMetrix, Inc.

(NURO) stock from Seeking Alpha. Read the news as it happens! See GlaxoSmithKline PLC ADR's 10 year historical growth, profitability, financial, efficiency, and cash flow ratios.

GlaxoSmithKline PLC Common Stock (GSK) Quote & Summary Data

Established in the year in India GlaxoSmithKline Pharmaceuticals Ltd. (GSK Rx India) is one of the oldest pharmaceuticals company and employs over people. Globally, GSK is a £ billion, leading, research-based healthcare and pharmaceutical company. In India, it is one of the market. Find the latest analyst research for GlaxoSmithKline PLC (GSK) at Stock quote for GlaxoSmithKline PLC Common Stock Common Stock (GSK) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq.

Financial analysis of gsk
Rated 0/5 based on 87 review
Brii Biosciences – Breakthrough innovation & insight